Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations
Molecules · 2025
DOI: 10.3390/molecules30132676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Zuzana Binova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technická 3, 166 28 Prague, Czech Republic. Hauptthemen laut MEDLINE: Cannabidiol, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Science Foundation, Infrastructure for Promoting Metrology in Food and Nutrition in the Czech Republic, Grants for specific University research.
Abstract (Originalsprache)
Cannabidiol (CBD), a phytocannabinoid commonly isolated from chemotype III Cannabis sativa plants, is known for its therapeutic potential. However, comprehensive information on its bioavailability is still lacking. The key objective of this study was to investigate the impact of specific formulations on CBD delivery to the site of action and, in particular, the brain of experimental animals. As brain tissue is an extremely complex matrix, a highly sensitive method employing liquid chromatography–tandem mass spectrometry (LC-MS/MS) had to be implemented. To make it applicable for multiple analytes, the method was validated for 17 other phytocannabinoids and selected metabolites. Using this method, a pharmacokinetic study was conducted on 200 brain samples collected from rats that had been administered various CBD formulations (carriers) via oral gavage. The peak concentration in brain occurred within 1–2 h; notably, the highest was reached with carriers containing triacylglycerols with the shortest fatty acid chains (caprylic/capric). In addition to the parent compound, 7-hydroxy-cannabidiol and 7-carboxy-cannabidiol were detected, confirming rapid post-administration metabolism. Overall, this research enhances understanding of CBD distribution in the brain and underscores the impact of specific formulations on its bioavailability, offering insights into optimizing CBD-based therapies to be both effective and ‘patient-friendly’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technická 3, 166 28 Prague, Czech Republic.
- Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague 6, Czech Republic.
- Institute for Clinical and Experimental Medicine, Vídeňská 1958, 140 21 Prague 4, Czech Republic.
ORCID-Profile: Zuzana Binova, Marie Zlechovcova, Matej Maly, Monika Cahova, Jana Hajslova
Förderung
- Czech Science Foundation
- Infrastructure for Promoting Metrology in Food and Nutrition in the Czech Republic
- Grants for specific University research
- infrastructure project
Zitieren
APA
Binova, Z., Benes, F., Zlechovcova, M., Maly, M., Kastanek, P., Cahova, M., Stranska, M., & Hajslova, J. (2025). Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations. Molecules. https://doi.org/10.3390/molecules30132676
Vancouver
Binova Z, Benes F, Zlechovcova M, Maly M, Kastanek P, Cahova M, et al. Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations. Molecules. 2025. doi:10.3390/molecules30132676
BibTeX
@article{Binova2025,
author = {Binova, Zuzana and Benes, Frantisek and Zlechovcova, Marie and Maly, Matej and Kastanek, Petr and Cahova, Monika and Stranska, Milena and Hajslova, Jana},
title = {Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30132676}
}
EUVIMED